Predictors of immune reconstitution syndrome in organ transplant recipients with cryptococcosis: implications for the management of immunosuppression
- PMID: 25210020
- PMCID: PMC6283360
- DOI: 10.1093/cid/ciu711
Predictors of immune reconstitution syndrome in organ transplant recipients with cryptococcosis: implications for the management of immunosuppression
Erratum in
-
Sun HY, et al (Clin Infect Dis 2015; 60:36-44).Clin Infect Dis. 2016 Jun 15;62(12):1621. doi: 10.1093/cid/ciw246. Epub 2016 Apr 28. Clin Infect Dis. 2016. PMID: 27126347 Free PMC article. No abstract available.
Abstract
Background: Risk factors including how changes in immunosuppression influence the occurrence of immune reconstitution syndrome (IRS) in solid organ transplant (SOT) recipients with cryptococcosis have not been fully defined.
Methods: SOT recipients with cryptococcosis were identified and followed for 12 months. IRS was defined based on previously proposed criteria.
Results: Of 89 SOT recipients, 13 (14%) developed IRS. Central nervous system (CNS) disease (adjusted odds ratio [AOR], 6.23; P = .03) and discontinuation of calcineurin inhibitor (AOR, 5.11; P = .02) were independently associated with IRS. Only 2.6% (1/13) of the patients without these risk factors developed IRS compared with 18.8% (6/32) with 1 risk factor, and 50% (6/12) with both risk factors (χ(2) for trend, P = .0001). Among patients with CNS disease, those with neuroimaging abnormalities (P = .03) were more likely to develop IRS, irrespective of serum or CSF cryptococcal antigen titers and fungemia. Graft rejection after cryptococcosis was observed in 15.4% (2/13) of the patients with IRS compared with 2.6% (2/76) of those without IRS (P = .07).
Conclusions: We determined variables that pose a risk for IRS and have shown that discontinuation of calcineurin inhibitors was independently associated with 5-fold increased risk of IRS in transplant recipients with cryptococcosis.
Keywords: Cryptococcus; fungal infections; immunosuppression; transplant.
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
Comment in
-
Editorial commentary: Immune reconstitution syndrome: how do we "tolerate" our microbiome?Clin Infect Dis. 2015 Jan 1;60(1):45-7. doi: 10.1093/cid/ciu717. Epub 2014 Sep 9. Clin Infect Dis. 2015. PMID: 25210022 No abstract available.
References
-
- Jabbour N, Reyes J, Kusne S, Martin M, Fung J. Cryptococcal meningitis after liver transplantation. Transplantation. 1996;61:146–67. - PubMed
-
- Person AK, Kontoyiannis DP, Alexander BD. Fungal infections in transplant and oncology patients. Hematol Oncol Clin North Am. 2011;25:193–213. - PubMed
-
- Perfect JR. Cryptococcosis. Infect Dis Clin North Am. 1989;3:77–102. - PubMed
-
- John GT, Mathew M, Snehaltha E, et al. Cryptococcosis in renal allograft recipients. Transplantation. 1994;58:855–6. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
